Cargando…

Retraction: Identification of Histone Deacetylase 3 as a Biomarker for Tumor Recurrence Following Liver Transplantation in HBV-Associated Hepatocellular Carcinoma

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2019
Materias:	Retraction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6668838/ https://www.ncbi.nlm.nih.gov/pubmed/31365574 http://dx.doi.org/10.1371/journal.pone.0220822

Ejemplares similares

Identification of Histone Deacetylase 3 as a Biomarker for Tumor Recurrence Following Liver Transplantation in HBV-Associated Hepatocellular Carcinoma
por: Wu, Li-Ming, et al.
Publicado: (2010)

Retraction: Genetic Variations in Plasma Circulating DNA of HBV-Related Hepatocellular Carcinoma Patients Predict Recurrence after Liver Transplantation
Publicado: (2019)

Retraction: A Scoring Model Based on Neutrophil to Lymphocyte Ratio Predicts Recurrence of HBV-Associated Hepatocellular Carcinoma after Liver Transplantation
Publicado: (2019)

Retraction: Salvage Liver Transplantation for Patients with Recurrent Hepatocellular Carcinoma after Curative Resection
Publicado: (2019)

Retraction: Salvage Liver Transplantation for Recurrent Hepatocellular Carcinoma after Liver Resection: Retrospective Study of the Milan and Hangzhou Criteria
Publicado: (2019)

Retraction: Dysferlin Interacts with Histone Deacetylase 6 and Increases alpha-Tubulin Acetylation
Publicado: (2018)

Retraction: Comparison of Steroid-Free Immunosuppression and Standard Immunosuppression for Liver Transplant Patients with Hepatocellular Carcinoma
Publicado: (2019)

Retraction: The Survival Benefit of Liver Transplantation for Hepatocellular Carcinoma Patients with Hepatitis B Virus Infection and Cirrhosis
Publicado: (2019)

Retracted: Value of 5-Hydroxymethylcytosine in HBV-Carrying High-Risk Hepatocellular Carcinoma Population: An Evaluation Based on Differential Analysis
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Retracted: Identification of the HMMR Gene as a Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma Based on Integrated Bioinformatics Analysis
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Retraction: Histone Deacetylase Inhibitors Sensitize Lung Cancer Cells to Hyperthermia: Involvement of Ku70/SirT-1 in Thermo-Protection
Publicado: (2020)

Retraction: Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation
Publicado: (2019)

Retracted: Identification of Key Biomarkers and Immune Infiltration in Liver Tissue after Bariatric Surgery
por: Markers, Disease
Publicado: (2023)

Histone Deacetylase Expressions in Hepatocellular Carcinoma and Functional Effects of Histone Deacetylase Inhibitors on Liver Cancer Cells In Vitro
por: Freese, Kim, et al.
Publicado: (2019)

Retraction: Comprehensive Comparison of Three Different Immunosuppressive Regimens for Liver Transplant Patients with Hepatocellular Carcinoma: Steroid-Free Immunosuppression, Induction Immunosuppression and Standard Immunosuppression
Publicado: (2019)

Retraction: De novo Cancers Following Liver Transplantation: A Single Center Experience in China
Publicado: (2019)

Retracted: Risk Factors for Brain Metastasis of Hepatocellular Carcinoma
por: Healthcare Engineering, Journal of
Publicado: (2023)

Retracted: G Protein Subunit Gamma 5 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Hepatocellular Carcinoma
por: Markers, Disease
Publicado: (2023)

Retracted: Comparison of 10-Year Survival Outcomes for Early Single Hepatocellular Carcinoma following Different Treatments
por: International, BioMed Research
Publicado: (2023)

Retracted: Identification and Validation of an Inflammatory Response-Related Polygenic Risk Score as a Prognostic Marker in Hepatocellular Carcinoma
por: Markers, Disease
Publicado: (2023)

Retracted: Recurrence of Early Hepatocellular Carcinoma after Surgery May Be Related to Intestinal Oxidative Stress and the Development of a Predictive Model
por: Longevity, Oxidative Medicine and Cellular
Publicado: (2023)

Retracted: The Relationship between Ultrasonographic Features of Hepatocellular Carcinoma and the Severity of Hepatocellular Carcinoma and the Expression of PTEN and Tg737
por: Healthcare Engineering, Journal of
Publicado: (2023)

Retracted: The Immune System in Hepatocellular Carcinoma and Potential New Immunotherapeutic Strategies
por: BioMed Research International,
Publicado: (2016)

Retracted: Hepatocellular Carcinoma: Novel Molecular Targets in Carcinogenesis for Future Therapies
por: BioMed Research International,
Publicado: (2018)

Retracted: microRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target
por: International, BioMed Research
Publicado: (2021)

[Retracted] KIFC1 promotes the proliferation of hepatocellular carcinoma in vitro and in vivo
por: Wang, Xing, et al.
Publicado: (2023)

Retracted: Analysis of Related Risk Factors of Microvascular Invasion in Hepatocellular Carcinoma
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Retraction: Artificial Liver Support System Combined with Liver Transplantation in the Treatment of Patients with Acute-on-Chronic Liver Failure
Publicado: (2019)

Retracted: Preliminary Evaluation of Artificial Intelligence-Based Anti-Hepatocellular Carcinoma Molecular Target Study in Hepatocellular Carcinoma Diagnosis Research
por: International, BioMed Research
Publicado: (2023)

Retracted: CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma
por: Longevity, Oxidative Medicine and Cellular
Publicado: (2023)

Retraction: Circulating FoxP3+ regulatory T and interleukin17-producing Th17 cells actively influence HBV clearance in de novo Hepatitis B virus infected patients after orthotopic liver transplantation
Publicado: (2019)

The real experience of patients after liver transplantation in intensive care unit: Retraction
Publicado: (2021)

Retraction: New Diagnosis and Therapy Model for Ischemic-Type Biliary Lesions following Liver Transplantation—A Retrospective Cohort Study
Publicado: (2019)

Retracted: Imaging Diagnosis and Interventional Treatment for Hepatocellular Carcinoma Combined with Arteriovenous Fistula
por: Healthcare Engineering, Journal of
Publicado: (2023)

Retracted: Immunogenomic Landscape Analysis of Prognostic Immune-Related Genes in Hepatocellular Carcinoma
por: Healthcare Engineering, Journal of
Publicado: (2023)

Retracted: Overexpressed RING Finger 44 Correlates with Poor Prognosis in Hepatocellular Carcinoma
por: Healthcare Engineering, Journal of
Publicado: (2023)

Retracted: Differentially Expressed Genes in Nasopharyngeal Carcinoma Tissues and Their Correlation with Recurrence and Metastasis of Nasopharyngeal Carcinoma
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Retracted: Analysis of Prognostic Factors and Treatment Modes of Patients with Recurrent Endometrial Carcinoma
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Retracted: Identification of Diagnostic Biomarkers of Rape Pollen Allergy Based on MRNA Sequencing
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Retracted: In Silico Identification of Hub Genes as Observing Biomarkers for Gastric Cancer Metastasis
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b87fgukrfd7q5q5o224eejdd4f